openPR Logo
Press release

Stents Market Projected to Gain Significant Value US$ 16.66 Billion by 2022 | Worldwide Key Players Abbott Laboratories, B. Braun Melsungen, Biotronik SE & Co., Boston Scientific Corporation

04-02-2019 10:29 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Stents Market

Stents Market

According to Allied Market Research the global stents market is expected to garner $16,666 million by 2022. In 2015, coronary stents was the largest segment in terms of value, whereas peripheral stents was the dominating market segment in terms of volume. Moreover, coronary stents market is projected to be the fastest growing segment in terms of both, value and volume, during 2016-2022. Asia-Pacific is expected to continue leading the geographic segment during the forecast period.

The coronary stents market has a huge potential with the presence of many players developing innovative technologies. Increasing advancements in the field of interventional cardiology coupled with the progress of minimally invasive techniques have significantly extended the potential of therapeutic applications of stents. Coronary stents such as bare metal stents, drug-eluting stents, and bioabsorbable stents can be used to treat coronary artery diseases (CAD).

Download Sample @ https://www.alliedmarketresearch.com/request-sample/1603?utm_source=openpr_ss

Bioabsorbable stent is expected to be the fastest growing segment, registering a CAGR of 37.2% during the forecast period. The major factors fueling the market growth are increasing focus on the development of bioabsorbable stents and their high adoption rate as they can be easily absorbed in the body and do not cause restenosis/thrombosis.

Metallic biomaterial is the dominant segment due to its cost effectiveness and the efficacy of vascular healing as compared to other stents. Natural biomaterials such as animal or plant origin materials have demonstrated several advantages over synthetic biomaterials. These are biocompatible, nontoxic, may also carry specific protein binding sites, and other biochemical signals that may assist in tissue healing or integration. The global natural biomaterial stents market is expected to grow at a CAGR of 10.5% from 2016 to 2022.

Key Market Players:
• Abbott Laboratories
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• C.R. Bard Inc.
• Elixir Medical Corporation
• Medtronic plc
• Microport Scientific Corporation
• STENTYS S.A.
• Terumo Corporation.

Flat 20% Discount on All License Type...
https://www.alliedmarketresearch.com/checkout/965155?utm_source=openpr_ss
* Offer Valid Till 20th April 2019

Key findings of the Stents Market:
• Coronary stent was the highest revenue-generating segment, accounting for around half of the total market in 2015, and is projected to grow at a CAGR of 9.5% during the forecast period.
• The bioabsorbable stents segment is projected to grow at a remarkable CAGR of 37.2%, owing to its growing adoption and technological advancements.
• The global synthetic grafts market is estimated to grow at a CAGR of 6.5% from 2016 to 2022.
• Asia-Pacific and Europe together accounted for over half of the share in the stents market in 2015.
• China and Japan are the leading markets in the Asia-Pacific region and are expected to continue their dominance throughout the forecast period.
• The South Africa stents market is estimated to garner $132 million by 2022.

In the current scenario, the U.S. and Europe have the largest customer base for stent implants. However, these regions constitute only 17% share of the world population. Whereas, the Asia-Pacific region constitute around 56.4% of the human population in 2015 (Source: United Nations Department of Economic & Social Affairs); with huge geriatric population; therefore, this region exhibits huge market potential.

According to the WHO, the geriatric population in the developing countries is projected to increase by 250% between 2010 and 2050, as compared to 71% in the developed countries. This is expected to increase the patient base in these regions. The Asia-Pacific region accounted for majority of the share in the stents market in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the increasing incidence of heart failures, changing lifestyle, improved reimbursement policies, and high adoption of advanced stents in the region.

Browse More Details @ https://www.alliedmarketresearch.com/stents-market?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stents Market Projected to Gain Significant Value US$ 16.66 Billion by 2022 | Worldwide Key Players Abbott Laboratories, B. Braun Melsungen, Biotronik SE & Co., Boston Scientific Corporation here

News-ID: 1682895 • Views: 317

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Stents

Ureteral Stents
Increasing prevalence of urinary incontinence with age and rising geriatric population are major factors expected to drive the ureteral stents market growth during the forecast period. According to the Global Forum for Incontinence held in 2014, incontinence is a serious medical condition and set of diseases, which affected 4% to 8% of the population or the lives of around 400 million people worldwide over a period of 2007-2010. Furthermore, lifestyle associated
Surgical Stents Market by Cardiac Stents, Urinary Stents, Biliary Stents, Esopha …
Surgical Stent Market Scenario: The stent is a small, flexible metal or plastic tube that is inserted into the vessels or duct to keep the passageway open. Different types of materials like metal, standard polymer, and biodegradable polymer are used for the preparation of the surgical stents. According to the WHO (2015), more than 35% of the total global population was suffering from major or minor cardiovascular complications; and in 2014,
Global Enteral Stents Market For 2017: By Product Type - Esophageal Stents, Gast …
Researchmoz added Most up-to-date research on "Global Enteral Stents Market For 2017: By Product Type - Esophageal Stents, Gastroduodenal Stents & Colon Stents" to its huge collection of research reports. In this report, the global Enteral Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report
Global Drug Eluting Stents (DES) Market: By Types - Nitinol Stents, Platinum chr …
Researchmoz added Most up-to-date research on "Global Drug Eluting Stents (DES) Market: By Types - Nitinol Stents, Platinum chromium alloy Stents, Stainless steel Stents & Other Materials" to its huge collection of research reports. This report studies Drug Eluting Stents (DES) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast
Europe's Coronary Stent Market: By Product Type - Bare Metal Stents, Drug Elutin …
Researchmoz added Most up-to-date research on "Europe's Coronary Stent Market: By Product Type - Bare Metal Stents, Drug Eluting Stents & Bio-absorbable Stents" to its huge collection of research reports. This report studies sales (consumption) of Coronary Stent in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries,
Japan's Coronary Stent Market: By Product Types - Bare Metal Stents, Drug Elutin …
Researchmoz added Most up-to-date research on "Japan's Coronary Stent Market: By Product Types - Bare Metal Stents, Drug Eluting Stents & Bio-absorbable Stents" to its huge collection of research reports. This report studies sales (consumption) of Coronary Stent in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Laboratories, Inc. Boston Scientific Corporation Medtronic, Inc. Johnson & Johnson Terumo Corporation B. Braun Melsungen AG C. R. Bard, Inc. Cook